ASSOCIATION OF EUROPEAN SCLERODERMA STUDY GROUP ACTIVITY INDEX (ESCSG-AI) WITH PROGRESSION PULMONARY ALTERATIONS BY HRCT IN PATIENTSWITH SYSTEMIC SCLEROSIS OVER A FIVE YEAR PERIOD

被引：1
|
作者：
Ovsyannikova, Olga [1 ]
Ananyeva, Lidia P. [1 ]
Koneva, Olga [1 ]
Garzanova, Liudmila [1 ]
Desinova, Oxana [1 ]
Starovoytova, Mayya [1 ]
机构：
[1] VA Nasonova Res Inst Rheumatol, Laborantory Microcirulat & Inflamat, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.6818
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0217
引用
收藏
页码：1565 / 1566
页数：2
相关论文
共 8 条
  • [1] ASSOCIATION OF EUROPEAN SCLERODERMA STUDY GROUP ACTIVITY INDEX WITH PROGRESSION PULMONARY ALTERATIONS BY HRCT IN PATIENTS WITH SYSTEMIC SCLEROSIS OVER A 5-YEAR PERIOD
    Ovsyannikova, Olga
    Ananyeva, Lidia
    Koneva, Olga A.
    Garzanova, Liudmila
    Shayakhmetova, Rushana
    Desinova, Oxana
    Starovoytova, Mayya
    Khelkovskaya-Sergeeva, Anna
    CHEST, 2023, 164 (04) : 5474A - 5474A
  • [2] ASSOCIATION OF DECREASE DIFFUSING LUNG CAPACITY WITH PROGRESSION PULMONARY ALTERATIONS BY HRCT IN PATIENTS WITH SYSTEMIC SCLEROSIS OVER A FIVE-YEAR PERIOD
    Ovsyannikova, O. B.
    Koneva, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1015 - 1015
  • [3] ASSOCIATION OF INFLAMMATORY MARKERS CREACTIVE PROTEIN AND ERYTHROCYTE SEDIMENTATION RATEWITH PULMONARY FUNCTION TESTS AND EUROPEAN SCLERODERMA STUDY GROUP ACTIVITY INDEX (ESCSG-AI) IN SYSTEMIC SCLEROSIS - ASSOCIATED INTERSTITIAL LUNG DISEASE IN FOLLOW UP STUDY
    Ovsyannikova, O. B.
    Koneva, O.
    Ananieva, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 423 - 424
  • [4] EUROPEAN SCLERODERMA STUDY GROUP ACTIVITY INDEX CAPTURES VARIATIONS IN DISEASE ACTIVITY OVER TIME AND PREDICTS ORGAN DAMAGE IN EARLY SYSTEMIC SCLEROSIS: DATA FROM THE CANADIAN SCLERODERMA RESEARCH GROUP
    Nevskaya, T.
    Baron, M.
    Pope, J. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 65 - 66
  • [5] IMPACT OF THE EUROPEAN SCLERODERMA STUDY GROUP ACTIVITY INDEX ON SURVIVAL OF SYSTEMIC SCLEROSIS PATIENTS FROM A SINGLE ITALIAN CENTER
    Vettori, S.
    Cuomo, G.
    Abignano, G.
    Iudici, M.
    Valentini, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S80 - S80
  • [6] Construct validity evaluation of the European Scleroderma Study Group activity index, and investigation of possible new disease activity markers in systemic sclerosis
    Minier, Tuende
    Nagy, Zoltan
    Balint, Zsofia
    Farkas, Helka
    Radics, Judit
    Kumanovics, Gabor
    Czompoly, Tamas
    Simon, Diana
    Varju, Cecilia
    Nemeth, Peter
    Czirjak, Laszlo
    RHEUMATOLOGY, 2010, 49 (06) : 1133 - 1145
  • [7] CONSTRUCT VALIDITY EVALUATION OF THE EUROPEAN SCLERODERMA STUDY GROUP ACTIVITY INDEX, AND INVESTIGATION OF POSSIBLE NEW DISEASE ACTIVITY MARKERS IN SYSTEMIC SCLEROSIS
    Minier, T.
    Nagy, Z.
    Balint, Z.
    Farkas, H.
    Radics, J.
    Kumanovics, G.
    Czompoly, T.
    Simon, D.
    Varju, C.
    Nemeth, P.
    Czirjak, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S115 - S116
  • [8] Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS)
    Bellando-Randone, Silvia
    Del Galdo, Francesco
    Lepri, Gemma
    Minier, Tunde
    Huscher, Doerte
    Furst, Daniel E.
    Allanore, Yannick
    Distler, Oliver
    Czirjak, Laszlo
    Bruni, Cosimo
    Guiducci, Serena
    Avouac, Jerome
    Cutolo, Maurizio
    Smith, Vanessa
    Matucci-Cerinic, Marco
    LANCET RHEUMATOLOGY, 2021, 3 (12): : E834 - E843
1